Manish is Global Chief Executive Officer (GCEO) of Teyro Labs since August 2019. He holds Master’s degrees in MSc.(Microbiology) & MBA (International Business). Manish possess rich experience of 28 years in pharmaceutical business. He started his career as Quality Professional and was associated with companies such as Lupin, Unichem, Sun Pharma, and held senior leadership positions at Strides, Mylan & Dr. Reddy’s. Manish has handled various global assignments in China, Latin America, Europe and North America and successfully managed responsibilities in pharmaceutical business operations . Through his previous roles, he has built a distinguished career spanning over two decades with deep understanding and experience in various aspects of the technical operations, R&D, Manufacturing, Quality, Regulatory and global pharmaceutical business.
At the helm of the Senior Management, Manish is leading & driving Teyro’s pharmaceutical business. He is creating and executing Teyro’s strategic growth roadmap and geographical footprint for the future to build the successful international pharmaceutical organisation reaching to patients across the world. Recognised as an action-oriented industry leader, Manish is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to shaping the healthcare business and making a difference to the lives of patients.
Shivaraj Katageri is Chief Scientific officer at Teyro bringing about 27 years of experience in Pharma Research & Development, Scale up, and Manufacturing of multiple pharmaceutical dosage forms comprising liquid aqueous, non-aqueous injections, suspension injections, Lyophilized Injectables, PFS and Parenteral formulations in Infusion bags, Tablets, Hard Gelatin capsules, Soft Gelatin capsules, semisolid formulations for Regulated markets such as US/EU/Australia and also for Emerging markets
He has developed and manufactured various specialty formulations including Cytotoxic and Hormone formulations and worked on Non-infringing(Para IV) and First to file formulations. Till so far filed about 10 patents applications and several national / international paper publications in various journals and filed over 80 ANDAs to USFDA and successfully commercialized more than 75products to various regulated markets including US/EU/Canada/Latam & etc. Prior to joining Teyro, he worked in reputed Pharmaceutical companies like Eugia (Aurobindo), Sun Pharma, Strides, Amneal, Pfizer & etc.